A legacy of hope

- Griffin, Cassandra P., Paul, Christine L., Lynam, James

ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.

- Lozinski, Mathew, Bowden, Nikola A., Graves, Moira C., Fay, Michael, Day, Bryan W., Stringer, Brett W., Tooney, Paul A.

Investigating the contribution of tumour cells to the vasculature of glioblastoma

- Maddison, Kelsey

Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: a systematic review

- Maddison, Kelsey, Bowden, Nikola A., Graves, Moira C., Tooney, Paul A.

Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy

- Dowdell, Amiee, Marsland, Mark, Faulkner, Sam, Gedye, Craig, Lynam, James, Griffin, Cassandra P., Marsland, Joanne, Jiang, Chen Chen, Hondermarck, Hubert

The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma

- Marsland, Mark, Dowdell, Amiee, Faulkner, Sam, Gedye, Craig, Lynam, James, Griffin, Cassandra P., Marsland, Joanne, Jiang, Chen Chen, Hondermarck, Hubert

Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma

- Maddison, Kelsey, Faulkner, Sam, Graves, Moira C., Fay, Michael, Bowden, Nikola A., Tooney, Paul A.

Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole

- Griffin, Cassandra P, Paul, Christine L, Alexander, Kimberley L, Walker, Marjorie M, Hondermarck, Hubert, Lynam, James

Transcriptomic Profiling of DNA Damage Response in Patient-Derived Glioblastoma Cells before and after Radiation and Temozolomide Treatment

- Lozinski, Mathew, Bowden, Nikola A., Graves, Moira C., Fay, Michael, Day, Bryan W., Stringer, Brett W., Tooney, Paul A.

Upconversion Nanoparticle-Based Cell Membrane-Coated cRGD Peptide Bioorthogonally Labeled Nanoplatform for Glioblastoma Treatment

- Mo, Jingxin, Chen, Xianjue, Li, Meiying, Liu, Wenxu, Zhao, Wei, Lim, Lee Yong, Tilley, Richard D., Gooding, J. Justin, Li, Qinghua

DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets

- Lozinski, Mathew, Bowden, Nikola A., Graves, Moira C., Fay, Michael, Tooney, Paul A.

Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma

- Maddison, Kelsey, Graves, Moira C., Bowden, Nikola A., Fay, Michael, Vilain, Ricardo E., Faulkner, Sam, Tooney, Paul A.

Mind Over Matter: Confronting Challenges in Post-Mortem Brain Biobanking for Glioblastoma Multiforme

- Griffin, Cassandra, Vilain, Ricardo, King, Simon, Nixon, Sandy, Gooley, Alisha, Bray, Samara, Lynam, James, Walker, Marjorie M., Scott, Rodney J., Paul, Christine

Intronic TP53 polymorphisms are associated with increased Δ133TP53 transcript, immune infiltration and cancer risk

- Eiholzer, Ramona A., Mehta, Sunali, Kazantseva, Marina, Drummond, Catherine J., McKinney, Cushla, Young, Katie, Slater, David, Morten, Brianna C., Avery-Kiejda, Kelly A., Lasham, Annette, Fleming, Nicholas, Morrin, Helen R., Reader, Karen, Royds, Janice A., Landmann, Michael, Petrich, Simone, Reddel, Roger, Huschtscha, Lily, Taha, Ahmad, Hung, Noelyn A., Slatter, Tania L., Braithwaite, Antony W.

Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients

- Climans, Seth A., Brandes, Alba A., Phillips, Claire, Roa, Wilson, Wick, Wolfgang, Winch, Chad, Mason, Warren P., Cairncross, J. Gregory, Ding, Keyue, Fay, Michael, Laperriere, Normand, Menten, Johan, Nishikawa, Ryo, O'Callaghan, Christopher J., Perry, James R.

Glioblastoma multiforme: an overview of emerging therapeutic targets

- Taylor, Olivia G., Brzozowski, Joshua S., Skelding, Kathryn A.

Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma

- Head, R. J., Fay, M. F., Cosgrove, L., Y C Fung, K., Rundle-Thiele, D., Martin, J. H.

Short-course radiation plus temozolomide in elderly patients with glioblastoma

- Perry, James R., Laperriere, Normand, Osoba, David, Rossiter, John P., Sahgal, Arjun, Hirte, Hal, Laigle-Donadey, Florence, Franceschi, Enrico, Chinot, Olivier, Golfinopoulos, Vassilis, Fariselli, Laura, Wick, Antje, O'Callaghan, Christopher J., Brandes, Alba A., Menten, Johan, Phillips, Claire, Fay, Michael, Nishikawa, Ryo, Cairncross, J. Gregory, Roa, Wilson

Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial

- Khasraw, Mustafa, Lee, Adrian, McCowatt, Sally, Kerestes, Zoltan, Buyse, Marc E., Back, Michael, Kichenadasse, Ganessan, Ackland, Stephen, Wheeler, Helen

Repurposing some older drugs that cross the blood-brainier and have potential anticancer activity to provide new treatment options for glioblastoma

- Rundle-Thiele, Dayle, Head, Richard, Cosgrove, Leah, Martin, Jennifer H.